It was found that 15-LOX-1 suppression using novel purine-pyrazole hybrids which contain thiazoles, thiazolidinones and rhodanines reduced the rate of viable MCF-7 cells and proposed to act as an anticancer compound in breast cancer [34, 72, 73]. Here, OLR1 is linked to breast carcinoma.